AEON

AEON Biopharma, Inc.

0.26 USD

Last updated Sep 4, 19:47 UTC

Yesterday HIGH

$0.27

Yesterday LOW

$0.25

52w HIGH

$1.45

52w LOW

$0.18

EPS

-0.02

PE

-13.08

Next Earnings

Nov 13, 2026

Overview News Insider Transactions Government Trades Fundamentals

AEON Biopharma, Inc. stock is down -9.79% since 30 days ago. The next earnings date is Nov 13, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 5 September’s closed higher than August. 100% of analysts rate it a buy.

Avi Kapoor

Wed Jul 15, 2026

Why Aehr Test Systems Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

Shares of Aehr Test Systems (NASDAQ: AEHR) jumped 29.6% to $93.30 in pre-market trading. Aehr Test Systems beats Q4 estimates and issues FY27 guidance above estimates.
Benzinga Newsdesk

Tue Jul 14, 2026

AEON Biopharma shares are trading lower after the company announced the pricing of its upsized $13.75 million offering.
Benzinga Newsdesk

Tue Jul 14, 2026

AEON Biopharma Prices Upsized $13.75M Public Offering Of 42,688,606 Shares At $0.3221/Share And And Accompanying Two-Year Milestone.
Avi Kapoor

Tue Jul 14, 2026

Why Vision Marine Technologies Shares Are Trading Higher By Over 60%; Here Are 20 Stocks Moving Premarket

Vision Marine Technologies Inc (NASDAQ: VMAR) gained 60.3% to $2.26 in pre-market trading after reporting third-quarter financial results with 27% jump in revenue. Other gainers and losers also listed.
Benzinga Insights

Thu Jul 9, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 178.9% to $8.87 during Thursday's regular session. The market value of their outstanding shares is at $2.5 million. Forte Biosciences (NASDAQ:FBRX) stock rose
Benzinga Insights

Thu Jul 9, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 134.0% to $7.44 during Thursday's pre-market session. The company's market cap stands at $2.5 million. Alnylam Pharmaceuticals (NASDAQ:ALNY) stock
Benzinga Newsdesk

Thu Jun 4, 2026

AEON Biopharma Presents New Analytical And Functional Data Supporting Biosimilarity Of ABP-450 To BOTOX At 68th Annual Scientific Meeting Of AHS

AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX® (onabotulinumtoxinA) for therapeutic use to achieve full-label U.S. market entry,
Benzinga Insights

Mon May 18, 2026

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Newsdesk

Thu May 14, 2026

AEON Biopharma Q1 EPS $(0.29) Misses $(0.13) Estimate

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.13) by 141.67 percent. This is a 112.72 percent decrease over earnings of $2.28 per share from
Benzinga Newsdesk

Mon Apr 6, 2026

Reported Friday, AEON Biopharma Receives Additional NYSE American Non-Compliance Notice Over $4M Stockholders' Equity Requirement Amid $55M Stockholders' Deficit